Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Pulmozyme fda approval?Bempedoic acid cholesterol generic availability?Dasatinib original patent wo 2001 bristol myers squibb?Provigil patent expiration?Are there patents on paclitaxel?
See the DrugPatentWatch profile for rayaldee
Rayaldee (calcifediol) is used to treat vitamin D deficiency in people with chronic kidney disease (CKD), especially when they are not getting enough vitamin D through sunlight or diet. It helps raise and maintain adequate vitamin D levels in the body.
In CKD, the kidneys may not convert vitamin D into its active forms efficiently. Rayaldee is a form of vitamin D (calcifediol) that is more directly usable by the body to support vitamin D status.
Rayaldee is prescribed as part of managing CKD-related vitamin D deficiency, a common issue that can contribute to problems with mineral balance.
Rayaldee is specifically indicated for vitamin D deficiency in people with CKD (the usual intended use is not for the general population). For people without CKD, clinicians may use other vitamin D products depending on the cause of deficiency.
Other Questions About Rayaldee :